Publications by authors named "Ryan Wilcox"

Claim this Profile
C
CDK9 is a dependency in GATA-3 driven and MCL-1 independent T-cell Lymphomas.
Chenguang Wang, Suhaib Abdelrahman, Xiangrong Geng, Alyssa Burgess, Ying S Hu, Ryan A Wilcox

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study.
Andrew L Feldman, Surendra Dasari, Lisa M Rimsza, David W Scott, Naoki Oishi, Ryan A Wilcox

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of mosunetuzumab and CAR-T cell therapy in relapsed/refractory follicular lymphoma.
Meng-Hsuan Lin, Jonathan Weiss, Tycel J Phillips, Dahlia Sano, Shannon A Carty, Ryan Wilcox

Leuk Lymphoma· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than skin deep.
Ryan A Wilcox

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.
Alexandra C Hristov, Trilokraj Tejasvi, Ryan A Wilcox

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Functional Dependence and Inhibition of the Bcl‑2 Pro-Survival Proteins in a Wide Spectrum of Cancers toward Precision Medicine.
Karson J Kump, Ejaz Ahmad, Charles Foucar, Rita A Avelar, Carlos Murga-Zamalloa, Ryan Wilcox

ACS Pharmacol Transl Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional Analysis of Effusion-Based Lymphoma Supports a Post-Germinal Center Origin and Specific Inflammatory Signal Background.
Vanessa Perez-Silos, Hojung Kim, Chenguang Wang, Alejandro Zevallos-Morales, Anthony Tipton, Ryan Wilcox

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.
Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain, Ryan A Wilcox

J Am Acad Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma.
Steven M Horwitz, Tatyana A Feldman, Jing Christine Ye, Michael S Khodadoust, Javier Munoz, Ryan A Wilcox

Leuk Lymphoma· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GATA-3-dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas.
Nermin Kady, Suhaib Abdelrahman, Ahmar M Rauf, Alyssa Burgess, Jonathan Weiss, Ryan A Wilcox

Blood· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.
Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain, Ryan A Wilcox

Transplant Cell Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of T-/natural killer cell lymphoproliferative neoplasms associated with systemic, chronic, active Epstein-Barr virus in adults: A report of 5 cases in a Western population.
Carlos Murga-Zamalloa, Michael Brandon Stone, Marc G Gutierrez, Neha Rajendra Hippalgaonkar, Hamza Tariq, Ryan Wilcox

Am J Clin Pathol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib in Patients With Solid Tumors With Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Vaibhav Sahai, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vijay Suhag, Ryan E Wilcox

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA-3-dependent Gene Transcription is Impaired upon HDAC Inhibition.
Xiangrong Geng, Chenguang Wang, Suhaib Abdelrahman, Thilini Perera, Badeia Saed, Ryan A Wilcox

Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program.
Jonathan Weiss, Kathryn Gibbons, Vida Ehyaee, Vanessa Perez-Silos, Alejandro Zevallos, Ryan A Wilcox

Am J Pathol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Challenges in peripheral T-cell lymphomas: from biological advances to clinical applicability.
Luís Alberto de Pádua Covas Lage, Juliana Pereira, Ryan A Wilcox

Front Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful anti-tumor effects with two novel bifunctional chemotherapeutic compounds that combine a LAT1 substrate with cytotoxic moieties in aggressive T-cell lymphomas.
Carlos Murga-Zamalloa, Shaun Webb, John Reneau, Alejandro Zevallos, Pierina Danos-Diaz, Ryan Wilcox

Leuk Res Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD30 expression in cutaneous B-cell lymphomas.
Olabisi Afolayan-Oloye, Lili Zhao, Trilokraj Tejasvi, May P Chan, Paul W Harms, Ryan A Wilcox

J Cutan Pathol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.
Tycel J Phillips, David Bond, Radihka Takiar, Karson Kump, Malalthi Kandarpa, Ryan A Wilcox

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target.
Shannon A Carty, Carlos A Murga-Zamalloa, Ryan A Wilcox

Clin Lymphoma Myeloma Leuk· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous B-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
Alexandra C Hristov, Trilokraj Tejasvi, Ryan A Wilcox

Am J Hematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
Marc Gutierrez, Patrick Bladek, Busra Goksu, Carlos Murga-Zamalloa, Dale Bixby, Ryan Wilcox

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.
Baishan Jiang, David M Weinstock, Katherine A Donovan, Hong-Wei Sun, Ashley Wolfe, Ryan A Wilcox

Cell Chem Biol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTCL, NOS: An update on classification, risk-stratification, and treatment.
Jonathan Weiss, John Reneau, Ryan A Wilcox

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas.
Xin Gao, Nermin Kady, Chenguang Wang, Suhaib Abdelrahman, Peter Gann, Ryan A Wilcox

Cancer Res Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis